$IBEX Cashflow Statement | Understand Stock

$IBEX

$46.21 -$0.88 (1.87%) Live

$IBEX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Income before taxation
Depreciation and amortization
Amortization of warrant asset
Foreign currency translation loss / (gain)
Fair value measurement of share warrants
Share-based payments
Allowance of expected credit losses
Share of profit from investment in joint venture
Gain on lease terminations
Provision for defined benefit scheme
Impairment of intangibles
Finance expenses
(Increase) / decrease in trade and other receivables
Decrease / (increase) in prepayments and other assets
Increase / (decrease) in trade and other payables and other liabilities
Cash inflow from operations
Interest paid
Income taxes paid
Net cash inflow from operating activities
Purchase of property and equipment
Purchase of other intangible assets
Dividend received from joint venture
Net cash outflow from investing activities
Proceeds from line of credit
Repayments of line of credit
Repayment of borrowings
Exercise of options
Proceeds from lease obligations
Principal payments on lease obligations
Purchase of treasury shares
Net cash (outflow) / inflow from financing activities
Net (decrease) / increase in cash and cash equivalents
New leases
Change in accounts payable related to fixed assets
CASH FLOWS FROM OPERATING ACTIVITIES
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Noncash lease expense
Noncash gain on lease terminations
Gain on sale of subsidiaries
Warrant contra revenue
Deferred income tax
Stock-based compensation expense
Allowance of expected credit losses
Impairment losses
Change in assets and liabilities:
Increase in accounts receivable
(Increase) / decrease in prepaid expenses and other current assets
Increase / (decrease) in accounts payable and accrued liabilities
Increase / (decrease) in deferred revenue
Decrease in operating lease liabilities
Net cash inflow from operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment
Cash outflow from sale of subsidiaries, net of cash received
Net cash outflow from investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from line of credit
Repayments of line of credit
Proceeds from debt
Repayment of related party loan
Repayment of debt
Net proceeds from initial public offering
Listing costs related to the initial public offering
Proceeds from the exercise of options
Taxes paid related to net share settlement of equity awards
Principal payments on finance leases
Purchase of treasury shares
Net cash outflow from financing activities

Effects of exchange rate difference on cash and cash equivalents
Net increase / (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of the year
Cash and cash equivalents at end of the year
Supplemental cash flow disclosures
Cash paid for interest
Cash paid for income taxes
Supplemental non-cash disclosures
Change in accounts payable related to fixed assets

Comments